Skip to content

Psychometric Properties of the German Translation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF)

Psychometric Properties of the German Translation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF) - HIS-Q_SF_German_Psychometrics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013092
Enrollment
100
Registered
2017-10-20
Start date
2017-10-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E29.1

Interventions

Group 1: Adult male patients of the Center of Reproductive Medicine and Andrology, who present with different conditions possibly related to hypogonadism Intervention: 100 male patients fill in the G

Sponsors

Klinik für Psychosomatik und Psychotherapie UKM
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: adult male patients of the Center of Reproductive Medicine and Andrology, at least 18 years old, who present themselves with different conditions possibly related to hypogonadism

Exclusion criteria

Exclusion criteria: Exclusion criteria will be current testosterone replacement therapy, current malignancies or severe somatic conditions and Klinefelter syndrome.

Design outcomes

Primary

MeasureTime frame
In order to assess the validity of the HIS-Q-SF, German Version, the 2 Primary endpoints are: 1) The correlation between the German version of the HIS-Q-SF total score and the AMS ; 2) The correlation between the German version of the HIS-Q-SF total score and free testosterone. Two primary hypotheses will be tested in a confirmatory sense: H1: The correlation between the German version of the HIS-Q-SF total score and the AMS total score is greater than 0.5. H2: The correlation between the German version of the HIS-Q-SF total score and free testosterone is negative. In order to check the reliability of the HIS-Q-SF (further primary endpoint), the correlation between the first completed HIS-Q-SF and ist repetition within 1 week will be assessed.

Secondary

MeasureTime frame
Further secondary objectives will be to assess the following correlations: HIS-Q-SF-D-Sexual with AMS-Sexual; HIS-Q-SF-D-Energy with AMS-Somatovegetative; HIS-Q-SF-D-Energy with SF-12-item Vitality; HIS-Q-SF-D-Sleep with AMS-items 04 and 05; HIS-Q-SF-D-mood with AMS-Psychological and PHQ-9 sum score; each particular HIS-Q-SF-D subscale with testosterone; HIS-Q-SF-D-total score and testosterone / CAGn-AR.

Countries

Germany

Contacts

Public ContactGudrun Schneider

Klinik für Psychosomatik und Psychotherapie UKM

Gudrun.Schneider@ukmuenster.de0251-8352902

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026